Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study

Fig. 2

Adjusted odds ratios (ORs) and 95% confidence intervals (CIs), and their trends of varieties of metabolic disorder diseases for quartiles of HOMA-IR. First quartile of HOMA-IR (Q1) in all subjects was set as reference. a Hypertension was defined as systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg. b Hypertriglyceridemia was defined as a TG level > 1.7 mmol/L. c High LDL-C level was defined as an LDL-C level > 3.4 mmol/L. d Hyperuricemia was defined as males and females at > 420 and 360 µmol/L, respectively. e Metabolic symptom was diagnosis as meeting at least three of the following criteria: (1) Waistline > 90 cm (male) and > 80 cm (female) and/or body mass index (BMI) ≥ 25 kg/m2; (2) elevated BPs (systolic blood pressure (SBP) > 125 mmHg and/or diastolic blood pressure (DBP) > 70 mmHg); (3) low HDL-C level; (4) fasting serum triglyceride ≥ 1.7 mmol/L; (5) fasting plasma glucose ≥ 5.6 mmol/L. f ALT elevation was defined as ALT > 40 U/L

Back to article page